HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suhn Hee Kim Selected Research

Pyrogallol

1/2009Pyrogallol inhibits the growth of lung cancer Calu-6 cells via caspase-dependent apoptosis.
1/2009Pyrogallol inhibits the growth of human pulmonary adenocarcinoma A549 cells by arresting cell cycle and triggering apoptosis.
11/2008Caspase inhibitor decreases apoptosis in pyrogallol-treated lung cancer Calu-6 cells via the prevention of GSH depletion.
9/2008Pyrogallol inhibits the growth of human lung cancer Calu-6 cells via arresting the cell cycle arrest.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Suhn Hee Kim Research Topics

Disease

14Lung Neoplasms (Lung Cancer)
05/2015 - 08/2008
12Ischemia
01/2021 - 06/2003
6Infarction (Infarctions)
03/2020 - 08/2012
6Hypertension (High Blood Pressure)
07/2015 - 06/2003
6Adenocarcinoma
12/2011 - 04/2008
5Inflammation (Inflammations)
11/2017 - 02/2011
5Cardiomegaly (Heart Hypertrophy)
07/2015 - 02/2004
4Necrosis
02/2015 - 05/2010
3Neoplasms (Cancer)
04/2020 - 12/2011
3Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 05/2010
3Reperfusion Injury
01/2018 - 08/2012
2Colitis
03/2022 - 04/2016
2Hypoxia (Hypoxemia)
11/2019 - 12/2010
2Uterine Cervical Neoplasms (Cancer of the Cervix)
02/2015 - 01/2010
2Erectile Dysfunction
01/2012 - 06/2011
2Hypertrophy
12/2008 - 07/2004
1Myocardial Infarction
01/2021
1Pulmonary Arterial Hypertension
07/2018
1Vascular Remodeling
07/2018
1Acute Kidney Injury (Acute Renal Failure)
07/2015
1Renovascular Hypertension (Goldblatt Syndrome)
07/2015
1Kidney Diseases (Kidney Disease)
12/2013
1Obesity
12/2013
1Alcoholic Fatty Liver
12/2013
1Insulin Resistance
12/2013

Drug/Important Bio-Agent (IBA)

15Atrial Natriuretic Factor (ANF)IBA
01/2021 - 06/2003
10Reactive Oxygen Species (Oxygen Radicals)IBA
04/2020 - 11/2008
9Glutathione (Reduced Glutathione)IBA
05/2015 - 11/2008
6L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2020 - 08/2012
5Krebs-Henseleit solutionIBA
01/2021 - 08/2012
5AntioxidantsIBA
05/2015 - 01/2008
4PyrogallolIBA
01/2009 - 09/2008
3Cysteine (L-Cysteine)FDA Link
01/2019 - 04/2010
3urotensin IIIBA
07/2015 - 12/2010
3Proteins (Proteins, Gene)FDA Link
12/2013 - 09/2008
3Matrix Metalloproteinases (MMPs)IBA
07/2013 - 05/2010
3Gallic AcidIBA
07/2013 - 05/2010
3angiotensin I (1-7)IBA
09/2012 - 05/2010
2Peptides (Polypeptides)IBA
03/2022 - 05/2010
2Dextran SulfateIBA
03/2022 - 04/2016
2AngiotensinsIBA
03/2022 - 07/2018
2KATP ChannelsIBA
11/2019 - 11/2013
2BuffersIBA
11/2019 - 04/2010
2MonocrotalineIBA
07/2018 - 12/2010
2EnzymesIBA
07/2018 - 05/2015
2Creatine Kinase (Creatine Phosphokinase)IBA
01/2016 - 05/2013
2Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
07/2015 - 09/2009
2AcidsIBA
05/2015 - 04/2012
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
07/2013 - 05/2010
2Proteasome InhibitorsIBA
04/2012 - 04/2010
2benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
04/2012 - 04/2010
2Arsenic Trioxide (Trisenox)FDA Link
04/2012 - 08/2008
2Phosphodiesterase 5 InhibitorsIBA
01/2012 - 06/2011
2Caspase InhibitorsIBA
11/2011 - 11/2008
2CaspasesIBA
11/2011 - 11/2008
2Protein Kinase CIBA
12/2010 - 06/2003
2Buthionine SulfoximineIBA
04/2010 - 08/2008
2Phospholipids (Phosphatides)FDA LinkGeneric
02/2004 - 06/2003
2Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
02/2004 - 06/2003
1angiotensin II (1-5)IBA
01/2021
1Liposomes (Liposome)IBA
04/2020
11-phenyl-3,3-dimethyltriazene (PDT)IBA
04/2020
1Caspase 3 (Caspase-3)IBA
04/2020
1DiarylheptanoidsIBA
04/2020
1PD 123319IBA
03/2020
1antineoplaston A10 (A 10)IBA
03/2020
1Losartan (Cozaar)FDA LinkGeneric
03/2020
1NG-Nitroarginine Methyl Ester (L-NAME)IBA
11/2019
12-chloro-5-nitrobenzanilideIBA
11/2019
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2019
1Glyburide (Glibenclamide)FDA LinkGeneric
11/2019
1sodium bisulfide (NaHS)IBA
11/2019
1Pinacidil (Pindac)FDA Link
11/2019
1Bosentan (Tracleer)FDA Link
11/2019
1Endothelin Receptors (Endothelin Receptor)IBA
11/2019
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2019
1angiotensin I (1-9)IBA
07/2018
1alamandineIBA
01/2018
1Angiopoietin-1IBA
11/2017
1Streptozocin (Streptozotocin)FDA Link
11/2017
1Natriuretic PeptidesIBA
04/2016
1Messenger RNA (mRNA)IBA
04/2016
1atrial natriuretic factor receptor AIBA
04/2016
1des-Asp(1)-des-Arg(2)-Ile(5)- angiotensin IIIBA
01/2016
1Brain Natriuretic Peptide (Natrecor)FDA Link
07/2015
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
07/2015
1Hormones (Hormone)IBA
07/2015
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
07/2015
1ProstaglandinsIBA
07/2015
1nimesulide (Aulin)IBA
07/2015
1ThioredoxinsIBA
05/2015
1Auranofin (Ridaura)FDA Link
02/2015
1Metformin (Glucophage)FDA LinkGeneric
12/2013
1CarbohydratesIBA
12/2013
1CatalaseIBA
11/2013
1Adenosine Triphosphate (ATP)IBA
11/2013
1Superoxide DismutaseIBA
11/2013
1Heme Oxygenase-1IBA
11/2013

Therapy/Procedure

1Therapeutics
04/2020
1Ligation
01/2016